×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| GUJARAT TERCE LABORATORIES LTD | 124.11 | -33.91 | 123.24 | -4.35 | 42.8 | |
| KMS Medisurgi Limited | NA | NA | NA | NA | 41.8 | 94.9 |
| ANG Lifesciences India Limited | 184.16 | -19.39 | 176.66 | -1.50 | 39.2 |
Gujarat Terce Laboratories Ltd, with Security Code 524314, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11.9 | 12.9 | 10.7 | 12.0 | 13.0 | 12.2 | 11.9 | 13.3 | 12.7 | 12.3 |
| Expenses | 11.8 | 13.1 | 11.8 | 11.5 | 12.2 | 11.2 | 11.8 | 11.6 | 11.6 | 11.2 |
| Operating Profit | 0.1 | -0.2 | -1.1 | 0.5 | 0.8 | 1.0 | 0.1 | 1.7 | 1.1 | 1.1 |
| OPM % | 1.02% | -1.51% | -10.53% | 4.51% | 6.51% | 8.22% | 0.65% | 12.49% | 8.6% | 8.89% |
| Other Income | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Interest | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Profit before tax | 0.0 | -0.4 | -1.3 | 0.3 | 0.7 | 0.8 | -0.1 | 1.5 | 1.0 | 1.0 |
| Tax % | 0% | -291.6% | 0% | 0% | 0% | -35.7% | 11.6% | -2.1% | 3.1% | -444.2% |
| Net Profit | 0.0 | 0.8 | -1.3 | 0.3 | 0.7 | 0.5 | -0.1 | 1.5 | 1.0 | -3.4 |
| EPS in Rs | 1.08 | -1.76 | 0.45 | 0.91 | 0.73 | -0.1 | 2 | 1.36 | -4.35 |
| Metrics | Sep 2019 | Dec 2019 |
|---|---|---|
| Sales | 11.1 | 10.1 |
| Expenses | 9.3 | 9.7 |
| Operating Profit | 1.8 | 0.5 |
| OPM % | 16.51% | 4.52% |
| Other Income | 0.0 | 0.0 |
| Interest | 0.1 | 0.0 |
| Depreciation | 0.1 | 0.1 |
| Profit before tax | 1.7 | 0.4 |
| Tax % | 0% | 0% |
| Net Profit | 1.7 | 0.4 |
| EPS in Rs | 0.23 | 0.5 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 9% |
| 3 Years: | 24% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -11% |
| 3 Years: | 28% |
| TTM: | 502% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 42% |
| 3 Years: | 13% |
| 1 Year: | 6% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -1000% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 42% |
| 3 Years: | 13% |
| 1 Year: | 6% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|